Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid withdrawal vs triple immunosuppression in kidney transplant recipients
2012-003298-24Phase 4Active
- Sponsor
- Sociedad Andaluza de Trasplantes de Órganos y Tejidos
- Start
- Apr 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prednisone in Kidney transplant recipient care and kidney allograft rejection (2 arms), sponsored by Sociedad Andaluza de Trasplantes de Órganos y Tejidos. Primary endpoint: Presence of de novo donor-specific anti-HLA antibodies at 24 months. Started Apr 2014; status: active.
02
Drugs
prednisone
03
Conditions
Kidney transplant recipient carekidney allograft rejection
Beyond the preview
Go deeper on 2012-003298-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003298-24.